Executive Order Could Lead To Big Subsidies For Domestic Biopharmaceutical Manufacturing

The president’s executive order on biomanufacturing could lead to a major law that bolsters domestic manufacturing of biologics in the same way that a 2021 executive order on supply chains precipitated the recently enacted law to give $52 billion in subsidies to domestic computer chip makers to bolster domestic manufacturing of semiconductors in the United States, according to executives at biopharmaceutical companies. The executive order also could be the beginning of a move away from the government paying to build...